IL-4 preferentially activates a novel STAT6 isoform in mast cells

Journal of Immunology

Volumn 162, Issue 5, 1999, Pages 2703-2708

  Sherman, Melanie A ^a   Secor, Virginia H ^a   Brown, Melissa A ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; STAT6 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; GENE ACTIVATION; GENE EXPRESSION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; INTERLEUKIN-4; MAST CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-4; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 0033105842     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Leonard, W. J., and J. J. O'Shea. 1998. JAKs and STATs: biological implications. Annu. Rev. Immunol. 16:293.
2. O'Shea, J. J. 1997. Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7:1.
3. Horvath, C. M., and J. E. J. Damell. 1996. The antiviral state induced by a interferon and γ interferon requires transcriptionally active Stat I protein. J. Virol. 70:647.
4. Wang, D., D. Stravopodis, S. Teglund, J. Kitazawa, and J. N. Ihle. 1996. Naturally occurring dominant negative variants of STAT5. Mol. Cell. Biol. 16:6141.
5. Caldenhoven, E., T. B. van Dijk, R. Solari, J. Armstrong, J. A. M. Raaijmakers, J. J. Lammers, L. Koenderman, and R. P. de Groot. 1996. STAT3β, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 271:13221.
6. Patel, B., J. H. Pierce, and W. J. La Rochelle. 1998. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human STAT6. Proc. Natl. Acad. Sci. USA 95:172.
7. Pierce, J. H., P. P. DiFiore, S. A. Aaronson, M. Potter, J. Pumphrey, A. Scott, and J. N. Ihle. 1985. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell 41:685.
8. Rothman, P., S. Li, B. Gorham, L. Glimcher, F. Alt, and M. Boothby. 1991. Identification of a conserved LPS/IL-4 responsive element located at the promoter of germline epsilon transcripts. Mol. Cell. Biol. 11:5551.
9. lo thymocytes in vivo. Science 250: 1720.
10. Yung, Y., R. Eger, G. Tertian, and M. A. S. Moore. 1981. Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J. Immunol. 127:794.
11. Kaplan, M. H., U. Schindler, S. T. Smiley, and M. J. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4:313.
12. Buckley, M. G., C. M. Williams, J. Thompson, P. Pryor, K. Ray, J. H. Butterfield, and J. W. Coleman. 1995. IL-4 enhances IL-3 and IL-8 gene expression in a human leukemic mast cell line. Immunology 84:410.
13. Lu, B., M. Reichel, D. A. Fisher, J. F. Smith, and P. Rothman. 1997. Identification of a STAT6 domain required for IL-4-induced activation of transcription. J. Immunol. 159:1255.
14. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248.
15. Lederer, J. A., V. L. Perez, L. DesRoches, S. M. Kim, A. K. Abbas, and A. H. Lichtman. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397.
16. Karras, J. G., Z. Wang, S. J. Coniglio, D. A. Frank, and T. L. Rothstein. 1996. Antigen-receptor engagement in B cells induces nuclear expression of STAT5 and STAT6 proteins that bind and transactivate an IFN-γ activation site. J. Immunol. 157:39.
17. Hou, J., U. Schindler, W. J. Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701.
18. Quelle, F. W., K. Shimoda, W. Thierfelder, C. Fischer, A. Kim, S. M. Ruben, J. L. Cleveleand, J. H. Pierce, A. D. Keegan, L. Nelms, W. E. Paul, and J. N. Ihle. 1995. Cloning of murine STAT6 and human STAT6: STAT proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15:3336.
19. Yu, C., R. Kirken, M. Malabarba, H. Young, and J. Ortaldo. 1998. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J. Immunol. 161:218.
20. Galli, S. J. 1990. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62:5.
21. Kotanides, H., and N. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262:1265.
22. Delphin, S., and J. Stavnezer. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline ∈ promoter: regulation by NF-IL-4, a C/EBP family member and NF-κB/p50. J. Exp. Med. 181: 181.
23. Fenghao, X., A. Saxon, A. Nguyen, Z. Ke, D. Diaz-Sanchez, and A. Nel. 1995. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-γ activation site-like sequence upstream of the I∈ exon in a human B cell line. J. Clin. Invest. 96:907.
24. Rothman, P., S. Lutzker, W. Cook, R. Coffman, and F. W. Alt. 1988. Mitogen plus interleukin 4 induction of C∈ transcripts in B lymphoid cells. J. Exp. Med. 168:2385.
25. Noelle, R., P. H. Krammer, J. Ohara, J. W. Uhr, and E. S. Vitetta. 1984. Increased expression of la antigens on resting B cells: an additional role for B-cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149.
26. Le Gros, G., S. Z. Ben-Sasson, R. Seder, F. D. Finkelman, and W. E. Paul. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
27. Swain, S. L., A. D. Weinberg, M. English, and G. Huston, 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
28. Hu, H. Z., Z. Du, S. Craig, G. Klish, N. Noben-Trauth, J. P. Kochan, T. F. Huff, A. M. Irani, and L. B. Schwartz. 1997. Effect of recombinant IL-4 on tryptase, chymase, and Fc epsilon receptor type 1 expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells. J. Immunol. 159:2911.
29. Toru, H., C. Ra, S. Nonoyama, K. Suzuki, J. Yata, and T. Nakahata. 1996. Induction of the high affinity IgE receptor (Fc∈RI) on human mast cells by IL-4. Int. Immunol. 8:1367.
30. Mosmann, T. R., M. W. Bond, R. L. Coffman, J. Ohara, and W. E. Paul. 1986. T-cell and mast cell lines respond to B-cell stimulatory factor I. Proc. Natl. Acad. Sci. USA 83:5654.
31. Rosen, R., K. Winestock, G. Chen, X. Liu, L. Hennighausen, and D. Finbloom. 1996. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes. Blood 88:1206.
32. Azam, M., C. Lee, I. Strehlow, and C. Schindler. 1997. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity 6:691.
33. Hentsch, B., A. Mouzaki, I. Pfeuffer, D. Rungger, and E. Serfling. 1992. The weak, fine-tuned binding of ubiquitous transcription factors to the IL-2 enhancer contributes to its T cell-restricted activity. Nucleic Acids Res. 20:2657.
34. Wasylyk, C., A. Gutman, R. Nicholson, and B. Wasylyk. 1991. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10:1127.
35. Paxton, L. L., L. J. Li, V. H. Secor, J. L. Duff, S. M. Naik, N. Shibagaki, and S. W. Caughman. 1997. Flanking sequences for the human intercellular adhesion molecule-1 NF-κB response element are necessary for tumor necrosis factor α-induced gene expression. J. Biol. Chem. 272:15928.
36. Schaefer, T. S., L. K. Sanders, O. K. Park, and D. Nathans. 1997. Functional differences between STAT3α and STAT3β. Mol. Cell. Biol. 17:5307.
37. Azam, M., H. Erdjument-Bromage, B. L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J. N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of STAT5. EMBO J. 14:1402.
38. Shaui, K., G. R. Stark, I. M. Kerr, and J. E. Darnell Jr. 1993. A single phosphotyrosine residue of STAT1 required for gene activation by interferon-γ. Science 261:1744.
39. Urban, J. F. J., N. Noben-Trauth, D. D. Donaldson, K. B. Madden, S. C. Morris, M. Collins, and F. D. Finkelman. 1998. IL-13, IL-4Rα, and STAT6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255.
40. Messner, B., A. M. Stutz, B. Albrecht, S. Peiritsch, and M. Woisetschlager. 1997. Cooperation of binding sites for STAT6 and NFκB/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J. Immunol. 159:3330.
41. Bennett, B. L., R. Cruz, R. G. Lacson, and A. M. Manning. 1997. Interleukin-4 suppression of tumor necrosis factor α-stimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-κB. J. Biol. Chem. 272:10212.
42. Iciek, L. A., S. A. Delphin, and J. Stavnezer. 1997. CD40 cross-linking induces Ig ∈ germline transcripts in B cells via activation of NF-κB: synergy with IL-4 induction. J. Immunol. 158:4769.
43. Shen, C., and J. Stavnezer. 1998. Interaction of STAT6 and NF-κB: direct association and synergistic activation of interleukin-4-induced transcription. Mol. Cell. Biol. 18:3395.
44. Sherman, M. A., V. H. Secor, S. K. Lee, R. D. Lopez, and M. A. Brown. 1999. STAT6-independent production of IL-4 by mast cells. Eur. J. Immunol. In press.